Search alternatives:
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
01 a » 1 a (Expand Search), 01 1 (Expand Search), 01 0 (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
01 a » 1 a (Expand Search), 01 1 (Expand Search), 01 0 (Expand Search)
-
361
-
362
-
363
-
364
The weighted clustering coefficient increases with fluctuations attain a peak by about May 01, 2020, and decreases to a stable value from July 2020.
Published 2022“…<p>The weighted clustering coefficient increases with fluctuations attain a peak by about May 01, 2020, and decreases to a stable value from July 2020.…”
-
365
-
366
-
367
-
368
-
369
-
370
-
371
Performance of selected antimalarials against field isolates during the study period.
Published 2024Subjects: -
372
-
373
Performance of selected drugs against field isolates during the study period.
Published 2024Subjects: -
374
Frequency of SNPs in <i>Pfmrp1</i> gene in field isolates during the study period.
Published 2024Subjects: -
375
<i>In vitro</i> susceptibility responses of field isolates to antimalarials during the study period.
Published 2024Subjects: -
376
-
377
-
378
Tyro 3 overexpression decreases the production of Aβ from 293APPswe cells and Gas6 inhibits the effect in a concentration-dependent manner.
Published 2012“…Both sets of cells were treated with different concentrations of Gas6 (12.5, 25, 50, 100 ng/ml). Total Aβ was also significantly lower in Tyro-3-transfected cells treated with low concentrations of Gas6 (12.5, 25 ng/ml) than in GFP controls. …”
-
379
AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: A randomized placebo-controlled trial
Published 2018“…AZP-531, a first-in-class UAG analog, was shown to inhibit the orexigenic effect of AG in animals, to improve glycemic control and decrease body weight in humans. We aimed to investigate the safety and efficacy of AZP-531 in patients with PWS for whom no approved treatment for hyperphagia is currently available.…”
-
380